Why Did Netflix Buy Warner Bros?
Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 | $217.3M | -- | -- | $0.99 | -- |
| 11/06/2025 | Q3 | $211.9M | $212.6M | -$4.30 | $0.95 | -$5.26 |
| 08/07/2025 | Q2 | $199.6M | $202.3M | $0.83 | $0.82 | $0.00 |
| 05/08/2025 | Q1 | $192M | $194.1M | $0.69 | $0.70 | -$0.01 |
| 02/27/2025 | Q4 | $195.6M | $197.3M | $0.45 | $0.81 | -$0.37 |
| 11/07/2024 | Q3 | $194.1M | $201.4M | $0.67 | $0.74 | -$0.06 |
| 08/08/2024 | Q2 | $194.9M | $197M | $0.52 | $0.61 | -$0.09 |
| 05/08/2024 | Q1 | $189.2M | $190.8M | $0.46 | $0.57 | -$0.11 |
| 02/15/2024 | Q4 | $195.7M | $192.2M | $0.34 | $0.62 | -$0.28 |
| 11/08/2023 | Q3 | -- | $196.3M | $0.22 | -- | -- |
| 08/03/2023 | Q2 | -- | $187.3M | $0.17 | -- | -- |
| 05/04/2023 | Q1 | -- | $181.2M | $0.42 | -- | -- |
| 02/16/2023 | Q4 | -- | $188.3M | $0.65 | -- | -- |
| 11/07/2022 | Q3 | -- | $186.6M | $0.69 | -- | -- |
| 08/04/2022 | Q2 | -- | $174.2M | $0.34 | -- | -- |
| 05/03/2022 | Q1 | -- | $163.5M | $0.66 | -- | -- |
| 02/23/2022 | Q4 | -- | $164.8M | $9.05 | -- | -- |
| 11/02/2021 | Q3 | -- | $163.2M | $0.78 | -- | -- |
| 08/12/2021 | Q2 | -- | $160.2M | $0.69 | -- | -- |
| 05/04/2021 | Q1 | -- | $157.2M | $0.55 | -- | -- |
| 02/11/2021 | Q4 | -- | $157.8M | $0.80 | -- | -- |
| 10/28/2020 | Q3 | -- | $150.4M | $0.54 | -- | -- |
| 07/30/2020 | Q2 | -- | $147.3M | $0.43 | -- | -- |
| 04/30/2020 | Q1 | -- | $173.5M | $0.67 | -- | -- |
| 02/20/2020 | Q4 | -- | $186.9M | $0.75 | -- | -- |
| 10/30/2019 | Q3 | -- | $181.1M | $0.70 | -- | -- |
| 08/05/2019 | Q2 | -- | $180.5M | $0.66 | -- | -- |
| 05/06/2019 | Q1 | -- | $172.6M | $0.64 | -- | -- |
| 02/28/2019 | Q4 | -- | $164.2M | $0.06 | -- | -- |
| 11/05/2018 | Q3 | -- | $159.8M | $0.36 | -- | -- |
| 08/06/2018 | Q2 | -- | $154.8M | $0.14 | -- | -- |
| 05/10/2018 | Q1 | -- | $150.5M | $0.22 | -- | -- |
| 02/28/2018 | Q4 | -- | $142.3M | $0.82 | -- | -- |
| 11/02/2017 | Q3 | -- | $138.7M | $0.41 | -- | -- |
| 08/03/2017 | Q2 | -- | $140.9M | $0.33 | -- | -- |
| 05/04/2017 | Q1 | -- | $136.3M | $0.18 | -- | -- |
| 03/06/2017 | Q4 | -- | $142.5M | $0.25 | -- | -- |
| 11/03/2016 | Q3 | -- | $132.6M | $0.44 | -- | -- |
| 08/04/2016 | Q2 | -- | $133.4M | $0.34 | -- | -- |
| 05/09/2016 | Q1 | -- | $142.1M | $1.21 | -- | -- |
| 03/14/2016 | Q4 | -- | -- | -- | -- | -- |
Ducommun, Inc. reported $212.6M worth of top line sales in its most recent quarter.
Ducommun, Inc. announced earnings per share of -$4.30 which represents a miss of analyst forecast a $0.95 per share.
Ducommun, Inc. reported $56.5M that represents $3.77 per share over the last quarter.
Ducommun, Inc.'s earnings are forecast to grow from $2.10 per share to $3.33 per share next year representing an increase of 76.13%.
Ducommun, Inc.'s next earnings date is February 26, 2026.
Signup to receive the latest stock alerts
Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Market Cap: $4.4T
P/E Ratio: 62x
Market Cap: $4.1T
P/E Ratio: 37x
Market Cap: $3.9T
P/E Ratio: 40x
SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.
Kymera Therapeutics, Inc. [KYMR] is up 41.67% over the past day.
Praxis Precision Medicines, Inc. [PRAX] is up 9.18% over the past day.